MarketPeel
Insider Trading Intelligence
Pricing
…
RL

Ra Capital Nexus Fund Iii, L.p.

MLYS
DIRECTOR · MINERALYS THERAPEUTICS, INC. · CIK 0001883840
FILING MIX · LIFETIME49%/51%
BUYS
74
SELLS
78
TOTAL VALUE
$1.02B
COMPANIES
9
ACTIVE SINCE
Feb 2023
HOLDINGS NOW
51,738,925
AVG SELL PX
$39.73
TRADE KIND
SHOWING 152 / 152
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
65 backtested trades · 8 horizons · 123 pending
Forward-return performance of every backtestable P/S trade by Ra Capital Nexus Fund Iii, L.p., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d65+47.69%+9.68%+1.16%+8.51%+10.69%4.90
14d65+66.15%+4.28%+1.72%+2.57%+0.10%1.16
30d65+24.62%+8.61%+1.27%+7.34%+7.05%3.17
60d65+50.77%+5.38%+2.60%+2.00%-2.56%0.54
90d65+69.23%+3.08%+3.39%-1.19%-8.28%-0.25
180d65(6 pending)+20.34%+13.64%+9.61%+4.03%-9.50%0.42
1y65(54 pending)+45.45%-5.01%+18.10%-23.11%-41.93%—
2y65(63 pending)+0.00%-43.37%+51.93%-95.30%-95.30%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
MLYS · 5,825,521 shares · as of Mar 30, 2026
01,456,3802,912,7614,369,1415,825,521202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 74 buys / 78 sellsCOVERAGE · 14 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CLYM
CLIMB BIO, INC.
PURCHASEGRANT
Stock grant
70,284——70,284Jun 29, 2026Jul 1, 2026 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
1,876$8.98$16.8K16,795,919Jun 26, 2026Jun 29, 2026 ↗View →
SEPN
SEPTERNA, INC.
PURCHASEGRANT
Stock grant
15,000——15,000Jun 26, 2026Jun 30, 2026 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
31,000$8.88$275.3K16,794,043Jun 25, 2026Jun 29, 2026 ↗View →
SION
SIONNA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
17,340——17,340Jun 17, 2026Jun 18, 2026 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
124,893$8.89$1.11M16,763,043Jun 16, 2026Jun 16, 2026 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
15,414$8.99$138.6K16,638,150Jun 15, 2026Jun 16, 2026 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
391,019$8.57$3.35M16,622,736Jun 12, 2026Jun 16, 2026 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
548,580$7.91$4.34M16,231,717Jun 11, 2026Jun 11, 2026 ↗View →
PBLS
PARABILIS MEDICINES, INC.
PURCHASE
1,187,881——1,187,881Jun 11, 2026Jun 15, 2026 ↗View →
PBLS
PARABILIS MEDICINES, INC.
SALE
9,445,363——0Jun 11, 2026Jun 15, 2026 ↗View →
PBLS
PARABILIS MEDICINES, INC.
SALE
642,250——0Jun 11, 2026Jun 15, 2026 ↗View →
PBLS
PARABILIS MEDICINES, INC.
SALE
160,562——0Jun 11, 2026Jun 15, 2026 ↗View →
PBLS
PARABILIS MEDICINES, INC.
PURCHASE
1,460,397$20.00$29.21M2,648,278Jun 11, 2026Jun 15, 2026 ↗View →
PBLS
PARABILIS MEDICINES, INC.
SALE
1,666,829——0Jun 11, 2026Jun 15, 2026 ↗View →
PBLS
PARABILIS MEDICINES, INC.
PURCHASE
6,556,740——6,556,740Jun 11, 2026Jun 15, 2026 ↗View →
PBLS
PARABILIS MEDICINES, INC.
PURCHASE
19,728,353$20.00$394.57M26,285,093Jun 11, 2026Jun 15, 2026 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
103$7.00$72115,683,137Jun 10, 2026Jun 11, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
19,475——19,475Jun 9, 2026Jun 10, 2026 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
479,039$6.91$3.31M15,683,034Jun 9, 2026Jun 11, 2026 ↗View →
CLYM
CLIMB BIO, INC.
PURCHASEGRANT
Stock grant
40,000——40,000Jun 5, 2026Jun 8, 2026 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
2,170,138$11.52$25.00M2,170,138May 11, 2026May 13, 2026 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
6,510,416$11.52$75.00M15,203,995May 11, 2026May 13, 2026 ↗View →
CLYM
CLIMB BIO, INC.
PURCHASEGRANT
Stock grant
2,106,000$9.50$20.01M22,546,000Apr 29, 2026Apr 29, 2026 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASE
58,300$24.16$1.41M5,825,521Mar 30, 2026Mar 31, 2026 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASE
310,700$23.67$7.35M5,767,221Mar 27, 2026Mar 31, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
2,200,000$16.00$35.20M2,200,000Feb 26, 2026Mar 2, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
300,000$16.00$4.80M4,603,418Feb 26, 2026Mar 2, 2026 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,200——6,200Feb 19, 2026Feb 20, 2026 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,300——8,300Feb 19, 2026Feb 20, 2026 ↗View →
EVMN
EVOMMUNE, INC.
PURCHASEGRANT
Stock grant
35,868$27.88$1000.0K2,710,293Feb 17, 2026Feb 17, 2026 ↗View →
SGP
SPYGLASS PHARMA, INC.
SALE
1,150,941——0Feb 9, 2026Feb 11, 2026 ↗View →
SGP
SPYGLASS PHARMA, INC.
SALE
272,056——0Feb 9, 2026Feb 11, 2026 ↗View →
SGP
SPYGLASS PHARMA, INC.
SALE
767,294——0Feb 9, 2026Feb 11, 2026 ↗View →
SGP
SPYGLASS PHARMA, INC.
PURCHASE
2,524,473——2,524,473Feb 9, 2026Feb 11, 2026 ↗View →
SGP
SPYGLASS PHARMA, INC.
SALE
767,294——0Feb 9, 2026Feb 11, 2026 ↗View →
SGP
SPYGLASS PHARMA, INC.
PURCHASE
3,441,966$16.00$55.07M5,966,439Feb 9, 2026Feb 11, 2026 ↗View →
SGP
SPYGLASS PHARMA, INC.
PURCHASE
248,034$16.00$3.97M2,054,678Feb 9, 2026Feb 11, 2026 ↗View →
SGP
SPYGLASS PHARMA, INC.
SALE
1,150,941——0Feb 9, 2026Feb 11, 2026 ↗View →
SGP
SPYGLASS PHARMA, INC.
PURCHASE
1,806,644——1,806,644Feb 9, 2026Feb 11, 2026 ↗View →
SGP
SPYGLASS PHARMA, INC.
SALE
222,591——0Feb 9, 2026Feb 11, 2026 ↗View →
SGP
SPYGLASS PHARMA, INC.
PURCHASEGRANT
Stock grant
27,400——27,400Feb 5, 2026Feb 9, 2026 ↗View →
CLYM
CLIMB BIO, INC.
PURCHASE
7,111$3.50$24.9K3,403,429Jan 5, 2026Jan 7, 2026 ↗View →
CLYM
CLIMB BIO, INC.
PURCHASE
101,462$2.86$290.2K3,396,318Dec 12, 2025Dec 15, 2025 ↗View →
CLYM
CLIMB BIO, INC.
SALE
20,440,000——3,081,757Dec 11, 2025Dec 15, 2025 ↗View →
CLYM
CLIMB BIO, INC.
PURCHASEGRANT
Stock grant
20,440,000——20,440,000Dec 11, 2025Dec 15, 2025 ↗View →
CLYM
CLIMB BIO, INC.
PURCHASE
213,099$2.18$464.6K3,294,856Dec 11, 2025Dec 15, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
1,210$39.50$47.8K6,897,623Nov 21, 2025Nov 24, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
6,440$39.50$254.4K2,198,082Nov 21, 2025Nov 24, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
7,609$39.50$300.6K159,033Nov 21, 2025Nov 24, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
9,924$39.50$392.0K650,307Nov 21, 2025Nov 24, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
96$40.50$3.9K6,898,833Nov 20, 2025Nov 24, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
604$40.50$24.5K166,642Nov 20, 2025Nov 24, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
512$40.50$20.7K2,204,522Nov 20, 2025Nov 24, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
150$39.89$6.0K6,898,929Nov 20, 2025Nov 24, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
801$39.89$32.0K2,205,034Nov 20, 2025Nov 24, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
947$39.89$37.8K167,246Nov 20, 2025Nov 24, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
1,235$39.89$49.3K661,019Nov 20, 2025Nov 24, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
788$40.50$31.9K660,231Nov 20, 2025Nov 24, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
2,276$40.01$91.1K6,899,081Nov 19, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
18,684$40.01$747.5K662,266Nov 19, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
8$40.61$3252,205,835Nov 19, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
12$40.61$487662,254Nov 19, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
14,325$40.01$573.1K168,202Nov 19, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
12,126$40.01$485.2K2,205,843Nov 19, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
9$40.61$365168,193Nov 19, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
2$40.61$816,899,079Nov 19, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
1,770$39.57$70.0K2,217,969Nov 18, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
2,728$39.57$107.9K680,950Nov 18, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
2,092$39.57$82.8K182,527Nov 18, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
332$39.57$13.1K6,901,357Nov 18, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
2,182$40.20$87.7K6,903,443Nov 17, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
17,913$40.20$720.1K698,075Nov 17, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
13,964$41.05$573.2K684,111Nov 17, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
10,707$41.05$439.5K184,950Nov 17, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
53$42.10$2.2K6,901,689Nov 17, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
1,701$41.05$69.8K6,901,742Nov 17, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
433$42.10$18.2K683,678Nov 17, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
9,063$41.05$372.0K2,220,019Nov 17, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
13,734$40.20$552.1K195,657Nov 17, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
331$42.10$13.9K184,619Nov 17, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
11,626$40.20$467.4K2,229,082Nov 17, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
280$42.10$11.8K2,219,739Nov 17, 2025Nov 19, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
31,392$39.58$1.24M715,988Oct 28, 2025Oct 28, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
17,118$39.58$677.5K2,240,708Oct 28, 2025Oct 28, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
3,624$39.58$143.4K6,905,625Oct 28, 2025Oct 28, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
10,476$39.58$414.6K209,391Oct 28, 2025Oct 28, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
66,672$39.50$2.63M2,257,826Oct 24, 2025Oct 28, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
122,271$39.50$4.83M747,380Oct 24, 2025Oct 28, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
14,116$39.50$557.6K6,909,249Oct 24, 2025Oct 28, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
107,941$39.50$4.26M219,867Oct 24, 2025Oct 28, 2025 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASE
1,176,470$25.50$30.00M5,456,521Sep 4, 2025Sep 8, 2025 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
13,750——13,750Jun 24, 2025Jun 26, 2025 ↗View →
SEPN
SEPTERNA, INC.
PURCHASEGRANT
Stock grant
16,623——16,623Jun 17, 2025Jun 20, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,959——19,959Jun 12, 2025Jun 16, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
23,746——23,746Jun 9, 2025Jun 10, 2025 ↗View →
CLYM
CLIMB BIO, INC.
PURCHASEGRANT
Stock grant
40,000——40,000Jun 4, 2025Jun 5, 2025 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASE
1,296,296$13.50$17.50M4,280,051Mar 13, 2025Mar 17, 2025 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
32,900——32,900Feb 13, 2025Feb 24, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
PURCHASE
179,975——327,808Feb 10, 2025Feb 10, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
1,229,830——0Feb 10, 2025Feb 10, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
PURCHASE
1,022,586$18.00$18.41M6,923,365Feb 10, 2025Feb 10, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
PURCHASE
102,414$18.00$1.84M2,324,498Feb 10, 2025Feb 10, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
PURCHASE
527,444——869,651Feb 10, 2025Feb 10, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
319,069——0Feb 10, 2025Feb 10, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
PURCHASE
5,021,990——5,900,779Feb 10, 2025Feb 10, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
138,054——0Feb 10, 2025Feb 10, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
923,773——0Feb 10, 2025Feb 10, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
PURCHASE
2,222,084——2,222,084Feb 10, 2025Feb 10, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
2,155,469——0Feb 10, 2025Feb 10, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
1,091,219——0Feb 10, 2025Feb 10, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
124,908——0Feb 10, 2025Feb 10, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
4,364,874——0Feb 10, 2025Feb 10, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
819,153——0Feb 10, 2025Feb 10, 2025 ↗View →
SION
SIONNA THERAPEUTICS, INC.
SALE
451,580——0Feb 10, 2025Feb 10, 2025 ↗View →
SEPN
SEPTERNA, INC.
PURCHASE
1,695,515——1,695,515Oct 28, 2024Oct 30, 2024 ↗View →
SEPN
SEPTERNA, INC.
PURCHASE
3,828,400$18.00$68.91M5,523,915Oct 28, 2024Oct 30, 2024 ↗View →
SEPN
SEPTERNA, INC.
SALE
9,732,596——0Oct 28, 2024Oct 30, 2024 ↗View →
SEPN
SEPTERNA, INC.
PURCHASE
341,600$18.00$6.15M1,471,943Oct 28, 2024Oct 30, 2024 ↗View →
SEPN
SEPTERNA, INC.
PURCHASE
1,130,343——1,130,343Oct 28, 2024Oct 30, 2024 ↗View →
SEPN
SEPTERNA, INC.
SALE
14,598,896——0Oct 28, 2024Oct 30, 2024 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
5,835,024——0Sep 16, 2024Sep 18, 2024 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
152,480$18.00$2.74M2,652,575Sep 16, 2024Sep 18, 2024 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
18,409,755——0Sep 16, 2024Sep 18, 2024 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
2,622,898——2,622,898Sep 16, 2024Sep 18, 2024 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
10,836,474——0Sep 16, 2024Sep 18, 2024 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
12,273,169——0Sep 16, 2024Sep 18, 2024 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
2,500,095——2,500,095Sep 16, 2024Sep 18, 2024 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
1,680,520$18.00$30.25M4,303,418Sep 16, 2024Sep 18, 2024 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
23,746——23,746Sep 12, 2024Sep 16, 2024 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
725,391——725,391Jul 22, 2024Jul 24, 2024 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
7,645,007$12.00$91.74M8,693,579Jul 22, 2024Jul 24, 2024 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
688,326$12.00$8.26M826,832Jul 22, 2024Jul 24, 2024 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
138,506$10.20$1.41M138,506Jul 22, 2024Jul 24, 2024 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
264,571——264,571Jul 22, 2024Jul 24, 2024 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
SALE
210,898——0Jul 22, 2024Jul 24, 2024 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
SALE
564,372——0Jul 22, 2024Jul 24, 2024 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
SALE
53,673——0Jul 22, 2024Jul 24, 2024 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
68,320——68,320Jul 22, 2024Jul 24, 2024 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
SALE
161,019——0Jul 22, 2024Jul 24, 2024 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
323,181$10.20$3.30M1,048,572Jul 22, 2024Jul 24, 2024 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
SALE
68,320——0Jul 22, 2024Jul 24, 2024 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,000——22,000May 22, 2024May 28, 2024 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
549,755$13.50$7.42M549,755Feb 12, 2024Feb 14, 2024 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,672,508$13.50$22.58M2,983,755Feb 12, 2024Feb 14, 2024 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASE
131,600$16.00$2.11M1,867,229Feb 14, 2023Feb 16, 2023 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASE
1,735,629——1,735,629Feb 14, 2023Feb 16, 2023 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASE
192,847——192,847Feb 14, 2023Feb 16, 2023 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE
1,735,629——0Feb 14, 2023Feb 16, 2023 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASE
1,118,400$16.00$17.89M1,311,247Feb 14, 2023Feb 16, 2023 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
SALE
192,847——0Feb 14, 2023Feb 16, 2023 ↗View →
MLYS
MINERALYS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
44,000——44,000Feb 9, 2023Feb 13, 2023 ↗View →
Other insiders · MLYS
Loading peer insiders…
About this filer
CIK 0001883840
ROLE
Director
PRIMARY
MLYS
COMPANIES
9
ACTIVE SINCE
Feb 2023
MARKETPEEL · /INSIDER/0001883840DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback